ArticleAnnals of the rheumatic diseases2023

Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry".

Ronald F van Vollenhoven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.